ACT reports net loss, but CEO says debt issues are behind them

... degenerative retinal disease in two Phase 1/2 studies, as well as several other candidates based on human stem cell research. After the...

http://www.bizjournals.com/boston/blog/bioflash/2013/03/act-reports-net-loss-but-ceo-says.html?ana=RSS&s=article_search&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+bizj_boston+%28Boston+Business+Journal%29